Form 4/A for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2022-03-03 00:00:00 ET · period of report 2022-02-10 · accession 0001062993-22-006643 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MA	2022-03-03	2022-02-10	COLL	Tupper Colleen	EVP, CFO	F - Tax	$17.63	-4,058	94.7K	-4%	-$71.5K
MA	2022-03-03	2022-02-10	COLL	Tupper Colleen	EVP, CFO	A - Grant	$0.00	+56.7K	94.5K	+150%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-10	F	D	2,821	$17.63	95,891	D	—	—	(F3) Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
2	Common	Common Stock	2022-02-10	F	D	1,237	$17.63	94,654	D	—	—	(F4) Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.
3	Common	Common Stock	2022-02-10	A	A	4,212	—	98,712	D	—	—	(F2) On February 10, 2022, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 4,212 performance share units granted in the issuer's prior fiscal year.
4	Common	Common Stock	2022-02-10	A	A	52,500	$0.00	94,500	D	—	—	(F1) Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2023, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.